Projects
Reading
People
Chat
SU\G
(𝔸)
/K·U
Projects
Reading
People
Chat
Sign Up
Light
Dark
System
Fabián Tibaldi
Follow
Share
Generating author description...
All published works
Action
Title
Year
Authors
+
Tree‐temporal scan statistics for safety signal detection in vaccine clinical trials
2024
François Haguinet
Fabián Tibaldi
Christophe Dessart
Andrew Bate
+
PDF
Chat
Assurance in vaccine efficacy clinical trial design based on immunological responses
2021
Andrea Callegaro
Toufik Zahaf
Fabián Tibaldi
+
PDF
Chat
Principal surrogates in context of high vaccine efficacy
2021
Andrea Callegaro
Fabián Tibaldi
Dean Follmann
+
PDF
Chat
Assessing correlates of protection in vaccine trials: statistical solutions in the context of high vaccine efficacy
2019
Andrea Callegaro
Fabián Tibaldi
+
Statistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development
2014
Andrea Callegaro
Marie Kassapian
Toufik Zahaf
Fabián Tibaldi
+
PDF
Chat
Nonlinear Fractional Polynomials for Estimating Long-Term Persistence of Induced Anti-HPV Antibodies: A Hierarchical Bayesian Approach
2014
Mehreteab Aregay
Ziv Shkedy
Geert Molenberghs
Marie‐Pierre David
Fabián Tibaldi
+
Nonlinear Fractional Polynomials for Estimating Long-Term Persistence of Induced Anti-HPV Antibodies: A Hierarchical Bayesian Approach
2014
Mehreteab Aregay
Ziv Shkedy
Geert Molenberghs
Marie‐Pierre David
Fabián Tibaldi
+
Linear Categorical Marginal Modeling of solicited symptoms in vaccine clinical trials
2013
Wicher Bergsma
Emmanuel Aris
Fabián Tibaldi
+
Linear Categorical Marginal Modeling of solicited symptoms in vaccine clinical trials
2013
Wicher Bergsma
Emmanuel Aris
Fabián Tibaldi
+
PDF
Chat
Linear Categorical Marginal Modeling of Solicited Symptoms in Vaccine Clinical Trials
2012
Wicher Bergsma
Emmanuel Aris
Fabián Tibaldi
+
Implementation of a Phase 1 Adaptive Clinical Trial in a Treatment of Type 2 Diabetes
2008
Fabián Tibaldi
Benoît Beck
Alun Bedding
+
PDF
Chat
Accounting for variability in individual hierarchical clinical trial data
2007
Fabián Tibaldi
Didier Renard
Geert Molenberghs
+
<i>The authors replied as follows:</i>
2007
Ariel Alonso
Geert Molenberghs
Tomasz Burzykowski
Didier Renard
Helena Geys
Ziv Shkedy
Fabián Tibaldi
José Cortiñas Abrahantes
Marc Buyse
+
Joint detection of important biomarkers and optimal dose–response model using penalties
2007
F. Vandenhende
Paul H.C. Eilers
Edouard Ledent
Didier Renard
Fabián Tibaldi
+
Conditional mixed models with crossed random effects
2006
Fabián Tibaldi
Geert Verbeke
Geert Molenberghs
Didier Renard
Wim Van Den Noortgate
Paul De Boeck
+
PDF
Chat
Prentice's Approach and the Meta‐Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
2004
Ariel Alonso
Geert Molenberghs
Tomasz Burzykowski
Didier Renard
Helena Geys
Ziv Shkedy
Fabián Tibaldi
José Cortiñas Abrahantes
Marc Buyse
+
Modelling associations between time‐to‐event responses in pilot cancer clinical trials using a Plackett–Dale model
2004
Fabián Tibaldi
Franz Torres Barbosa
Geert Molenberghs
+
PDF
Chat
Pseudo‐likelihood estimation for a marginal multivariate survival model
2004
Fabián Tibaldi
Geert Molenberghs
Tomasz Burzykowski
Helena Geys
+
PDF
Chat
Simplified hierarchical linear models for the evaluation of surrogate endpoints
2003
Fabián Tibaldi
José Cortiñas Abrahantes
Geert Molenberghs
Didier Renard
Tomasz Burzykowski
Marc Buyse
Max Parmar
Theo Stijnen
Russ Wolfinger
+
Statistical software for calculating properly weighted estimates form Health Interview Survey Data
2003
Fabián Tibaldi
Herman Van Oyen
Johan Van der Heyden
Liesbeth Bruckers
Geert Molenberghs
+
Multivariate Plackett-Dale inference to study the inheritance of longevity in a Belgian village
2003
Fabián Tibaldi
Bart Van de Putte
Helena Geys
Geert Molenberghs
Koenraad Matthijs
Robert Vlietinck
+
Methodology of the validation of surrogate endpoints in multiple randomized experiments
2001
Geert Molenberghs
Ariel Alonso
Tomasz Burzykowski
Jose Cortinas Abrahantas
Helena Geys
Didier Renard
Ziv Shkedy
Fabián Tibaldi
Marc Buyse
Common Coauthors
Coauthor
Papers Together
Geert Molenberghs
12
Didier Renard
7
Ziv Shkedy
5
Tomasz Burzykowski
5
Helena Geys
5
Marc Buyse
4
Andrea Callegaro
4
Ariel Alonso
3
Emmanuel Aris
3
José Cortiñas Abrahantes
3
Wicher Bergsma
3
Toufik Zahaf
2
Mehreteab Aregay
2
Marie‐Pierre David
2
Marie Kassapian
1
Franz Torres Barbosa
1
Bart Van de Putte
1
Benoît Beck
1
Theo Stijnen
1
Paul H.C. Eilers
1
F. Vandenhende
1
Koenraad Matthijs
1
Alun Bedding
1
Andrew Bate
1
Max Parmar
1
Russ Wolfinger
1
Robert Vlietinck
1
Geert Verbeke
1
Jose Cortinas Abrahantas
1
Johan Van der Heyden
1
Wim Van Den Noortgate
1
Edouard Ledent
1
François Haguinet
1
Christophe Dessart
1
Herman Van Oyen
1
Liesbeth Bruckers
1
Dean Follmann
1
Paul De Boeck
1
Commonly Cited References
Action
Title
Year
Authors
# of times referenced
+
PDF
Chat
The validation of surrogate endpoints in meta-analyses of randomized experiments
2000
Marc Buyse
Geert Molenberghs
Tomasz Burzykowski
Didier Renard
Helena Geys
7
+
Surrogate endpoints in clinical trials: Definition and operational criteria
1989
Ross L. Prentice
7
+
Statistical validation of intermediate endpoints for chronic diseases
1992
Laurence S. Freedman
Barry I. Graubard
Arthur Schatzkin
6
+
PDF
Chat
Principal Stratification in Causal Inference
2002
Constantine Frangakis
Donald B. Rubin
4
+
Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
1998
Marc Buyse
Geert Molenberghs
4
+
PDF
Chat
On meta-analytic assessment of surrogate outcomes
2000
Mitchell H. Gail
Ruth M. Pfeiffer
Hans C. van Houwelingen
Raymond J. Carroll
4
+
Meta-analysis for the evaluation of potential surrogate markers
1997
Michael J. Daniels
Michael D. Hughes
4
+
PDF
Chat
Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
2001
Tomasz Burzykowski
Geert Molenberghs
Marc Buyse
Helena Geys
Didier Renard
3
+
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
2002
Hans C. van Houwelingen
Lidia R. Arends
Theo Stijnen
3
+
PDF
Chat
Simplified hierarchical linear models for the evaluation of surrogate endpoints
2003
Fabián Tibaldi
José Cortiñas Abrahantes
Geert Molenberghs
Didier Renard
Tomasz Burzykowski
Marc Buyse
Max Parmar
Theo Stijnen
Russ Wolfinger
3
+
Longitudinal data analysis using generalized linear models
1986
Kung‐Yee Liang
Scott L. Zeger
3
+
Logistic Regression for Correlated Binary Data
1994
Saskia le Cessie
Hans C. van Houwelingen
3
+
A Class of Bivariate Distributions
1965
R. L. Plackett
3
+
Families of Bivariate Distributions
1973
V. S. Huzurbazar
Kanti V. Mardia
3
+
PDF
Chat
Augmented Designs to Assess Immune Response in Vaccine Trials
2006
Dean Follmann
3
+
Global Cross-Ratio Models for Bivariate, Discrete, Ordered Responses
1986
Jocelyn R. Dale
3
+
Pseudolikelihood Modeling of Multivariate Outcomes in Developmental Toxicology
1999
Helena Geys
Geert Molenberghs
Louise Ryan
3
+
Surrogate End Points in Clinical Trials: Are We Being Misled?
1996
Thomas R. Fleming
2
+
PDF
Chat
On the Relationship between the Causal-Inference and Meta-Analytic Paradigms for the Validation of Surrogate Endpoints
2014
Ariel Alonso
Wim Van der Elst
Geert Molenberghs
Marc Buyse
Tomasz Burzykowski
2
+
PSEUDOLIKELIHOOD ESTIMATION : SOME EXAMPLES
2016
Barry C. Arnold
David Strauss
2
+
PDF
Chat
Marginal modelling of multivariate categorical data
1999
Geert Molenberghs
Emmanuel Lesaffre
2
+
Multivariate Models and Multivariate Dependence Concepts
1997
Harry Joe
2
+
Families of Bivariate Distributions.
1971
J. K. Ord
Kanti V. Mardia
2
+
PDF
Chat
Marginal Modeling of Correlated Ordinal Data Using a Multivariate Plackett Distribution
1994
Geert Molenberghs
Emmanuel Lesaffre
2
+
Use of the false discovery rate for evaluating clinical safety data
2004
Devan V. Mehrotra
Joseph F. Heyse
2
+
PDF
Chat
Assessing correlates of protection in vaccine trials: statistical solutions in the context of high vaccine efficacy
2019
Andrea Callegaro
Fabián Tibaldi
2
+
Multilevel covariance component models
1987
Harvey Goldstein
2
+
PDF
Chat
The Validation of Surrogate End Points by using Data from Randomized Clinical Trials: A Case-Study in Advanced Colorectal Cancer
2003
Tomasz Burzykowski
Geert Molenberghs
Marc Buyse
2
+
Inferences on the Association Parameter in Copula Models for Bivariate Survival Data
1995
Joanna H. Shih
Thomas Louis
2
+
Simultaneously Modeling Joint and Marginal Distributions of Multivariate Categorical Responses
1994
Joseph B. Lang
Alan Agresti
2
+
PDF
Chat
On Nonparametric Measures of Dependence for Random Variables
1981
B. Schweizer
Edward F. Wolff
2
+
The Joy of Copulas: Bivariate Distributions with Uniform Marginals
1986
Christian Genest
Jock MacKay
2
+
<b>R2WinBUGS</b>: A Package for Running<b>WinBUGS</b>from<i>R</i>
2005
Sibylle Sturtz
Uwe Ligges
Andrew Gelman
2
+
Regression Using Fractional Polynomials of Continuous Covariates: Parsimonious Parametric Modelling
1994
Patrick Royston
Douglas G. Altman
2
+
ASTIN: a Bayesian adaptive dose–response trial in acute stroke
2005
Andrew P. Grieve
Michael Krams
1
+
Bivariate Survival Models Induced by Frailties
1989
David Oakes
1
+
PDF
Chat
Validation of a longitudinally measured surrogate marker for a time-to-event endpoint
2003
Didier Renard
Helena Geys
Geert Molenberghs
Tomasz Burzykowski
Marc Buyse
Tony Vangeneugden
Luc Bijnens
1
+
The advantages and disadvantages of adaptive designs for clinical trials
2004
Péter Bauer
Werner Brannath
1
+
Quantifying the Effect of the Surrogate Marker by Information Gain
2007
Yongming Qu
Michael Case
1
+
Data Mining and Statistically Guided Clinical Review of Adverse Event Data in Clinical Trials
2009
Sue Southworth
Mark O’Connell
1
+
Maximum Likelihood Approaches to Variance Component Estimation and to Related Problems
1977
David A. Harville
1
+
PDF
Chat
Bayesian probability of success for clinical trials using historical data
2014
Joseph G. Ibrahim
Ming‐Hui Chen
Mani Lakshminarayanan
G. Frank Liu
Joseph F. Heyse
1
+
Bayesian inference for variance components using only error contrasts
1974
David A. Harville
1
+
Approximate Inference in Generalized Linear Mixed Models
1993
N. E. Breslow
David Clayton
1
+
PDF
Chat
Linear Mixed Models for Longitudinal Data
1997
Geert Verbeke
1
+
PDF
Chat
Ethically optimised designs.
1982
D. G. Clayton
1
+
Discrete Longitudinal Data
2006
Hulin Wu
Jin‐Ting Zhang
1
+
A Composite Likelihood Approach to Multivariate Survival Data
2001
Erik Thorlund Parner
1
+
Conditional Linear Mixed Models
2001
Geert Verbeke
Bart Spiessens
Emmanuel Lesaffre
1
+
PDF
Chat
A perfect correlate does not a surrogate make
2003
Stuart G. Baker
Barnett S. Kramer
1